Leadership Overview
Torrent Pharma has 7 executives leading key functions including strategy, finance, technology, operations, quality assurance, and management.
Driven by scientific excellence, Torrent Pharma is dedicated to developing high-quality, affordable medicines for patients worldwide, maintaining a strong international presence and leadership across key therapeutic areas.
Driven by scientific excellence, Torrent Pharma is dedicated to developing high-quality, affordable medicines for patients worldwide, maintaining a strong international presence and leadership across key therapeutic areas.
Leadership Roles at Torrent Pharma
Ankur Jain - Chief Executive Officer
Ankur Jain, the Chief Executive Officer at Torrent Pharma, directs the company's overarching strategy and global operations. Jain spearheads initiatives focused on expanding market reach and solidifying Torrent Pharma's position as a leading pharmaceutical enterprise in India and internationally. This leadership role involves guiding research and development efforts, ensuring alignment with market needs, and fostering innovation across all therapeutic areas. Jain's strategic vision drives the company's commitment to delivering high-quality, affordable medicines. By overseeing critical business functions, Ankur Jain ensures the company's sustained growth and its mission to improve patient outcomes worldwide. The Chief Executive Officer's purview encompasses all aspects of the business, from product development to market penetration, ensuring operational excellence and financial health.
Joseph Del Buono - Chief Financial Officer
Joseph Del Buono, the Chief Financial Officer at Torrent Pharma, manages the company's financial health and strategic fiscal planning. Del Buono oversees all financial operations, including budgeting, forecasting, and investment strategies, ensuring robust financial performance and compliance. This role is critical in supporting Torrent Pharma's expansion initiatives and its commitment to developing affordable medicines. By optimizing financial resources, Del Buono directly contributes to the company's ability to invest in cutting-edge research and development. Joseph Del Buono's expertise guides the company's financial direction, enabling sustainable growth and reinforcing its market leadership in key therapeutic areas. The Chief Financial Officer's responsibilities extend to managing investor relations and ensuring fiscal discipline across all global operations.
Sudhir Menon - Executive Director & Chief Financial Officer
Sudhir Menon, the Executive Director & Chief Financial Officer at Torrent Pharma, provides strategic financial leadership and oversight. Menon collaborates with the Chief Executive Officer to shape financial strategies that support Torrent Pharma's growth objectives and international expansion. This dual role emphasizes a deep involvement in both financial management and executive decision-making, ensuring fiscal responsibility across all operations. Sudhir Menon's expertise is crucial for navigating complex financial markets and optimizing resource allocation for research and development. Menon's leadership ensures the company's financial stability and its capacity to deliver affordable, high-quality medicines. The Executive Director & Chief Financial Officer's influence extends to corporate governance and long-term financial planning.
Hasmukh Patel - Chief Operating Officer
Hasmukh Patel, the Chief Operating Officer at Torrent Pharma, directs the company's day-to-day operational activities and manufacturing processes. Patel ensures the efficient and high-quality production of pharmaceuticals, overseeing supply chain management and operational scaling to meet global demand. This role is fundamental to Torrent Pharma's mission of delivering affordable medicines across key therapeutic areas. By optimizing manufacturing workflows and ensuring adherence to stringent quality standards, Hasmukh Patel supports the company's robust international presence. Patel's operational leadership guarantees the reliable supply of products. The Chief Operating Officer's responsibilities include managing production facilities and driving continuous improvement in operational effectiveness.
Geena Malhotra - Chief Technology Officer
Geena Malhotra, the Chief Technology Officer at Torrent Pharma, architects the company's technological infrastructure and digital transformation strategies. Malhotra drives innovation in information technology, ensuring advanced systems support research, manufacturing, and global distribution. This leadership position is vital for enhancing operational efficiency and maintaining Torrent Pharma's competitive edge in the pharmaceutical sector. By leveraging technology, Geena Malhotra enables the development of high-quality medicines and supports the company's expanding international presence. Malhotra's focus on technological advancement directly impacts the company's ability to meet patient needs effectively. The Chief Technology Officer oversees cybersecurity, data management, and the implementation of new digital tools across all departments.

Vidyasagar Gotpagar - Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations )
Vidyasagar Gotpagar, the Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations ) at Torrent Pharma, oversees critical quality assurance functions, particularly concerning contract manufacturing operations. Gotpagar ensures that all products manufactured through third-party agreements meet Torrent Pharma's rigorous quality standards and regulatory requirements. This specialized role is essential for maintaining the integrity and efficacy of the company's diverse product portfolio, including cardiovascular health and central nervous system treatments. Vidyasagar Gotpagar's diligent monitoring at various locations guarantees compliance and product safety. The Executive LLM's focus on quality assurance supports Torrent Pharma's reputation for excellence and its commitment to patient well-being.
Akash Vimal - Senior Executive Manager
Akash Vimal, the Senior Executive Manager at Torrent Pharma, manages key initiatives that drive operational efficiency and strategic execution. Vimal supports the executive leadership team in implementing business strategies across various departments, ensuring alignment with Torrent Pharma's core mission. This role involves coordinating cross-functional projects and contributing to the company's market presence in critical therapeutic areas. Akash Vimal's contributions are vital for enhancing the company's operational capabilities and supporting its commitment to developing affordable medicines. Vimal plays a key part in ensuring that strategic objectives translate into tangible business outcomes. The Senior Executive Manager's responsibilities include project oversight and facilitating effective communication across the organization.
Explore Leadership Teams in Manufacturing
Zydus is a global pharmaceutical company headquartered in Ahmedabad, India. Founded in 1952, the company operates manufacturing sites and research facilities across multiple states in India as well as in the United States and Brazil. Zydus specializes in developing, manufacturing, and distributing pharmaceutical products with a significant global footprint. The company maintains a strong presence in regulated markets including the United States, Europe, Latin America, and South Africa, while also serving numerous emerging markets worldwide. Zydus offers a comprehensive portfolio of pharmaceutical products and services, supported by extensive research and development capabilities.
Company Leadership HW
AB
TS
Founded in 1947 and headquartered in Mumbai, Indoco Remedies Limited is a fully integrated, research-oriented pharma company. Indoco specializes in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
Company Leadership
AR
AK
BD
American Regent, Inc, a Daiichi Sankyo Group Company, develops, manufactures, and supplies high quality sterile injectables for healthcare providers, clinics and hospitals across the United States and Canada. We have locations in New York, Ohio, and Pennsylvania and sales territories nationwide.
Company Leadership
RT

JO
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat specific forms of advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan.
Company Leadership
CP
CO
GP